Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ProPhase Labs, Inc. PRPH
$7.84
-$0.61 (-7.76%)
На 18:01, 12 мая 2023
+78.57%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
141173838.00000000
-
week52high
15.25
-
week52low
6.31
-
Revenue
122647000
-
P/E TTM
7
-
Beta
-0.32733500
-
EPS
1.06000000
-
Last Dividend
0.30000000
-
Next Earnings Date
11 мая 2023 г. в 12:30
Описание компании
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 17 мая 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 31 мар 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 14 янв 2022 г. |
| HC Wainwright & Co. | Buy | 20 дек 2021 г. | |
| Dawson James | Neutral | Buy | 13 окт 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 11 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Karkus Ted William | D | 0 | 500000 | 01 февр 2023 г. |
| Karkus Ted William | D | 3583750 | 268337 | 01 февр 2023 г. |
| Karkus Ted William | A | 3852087 | 500000 | 01 февр 2023 г. |
| Karkus Ted William | D | 500000 | 600000 | 13 янв 2023 г. |
| Karkus Ted William | D | 3352087 | 319231 | 13 янв 2023 г. |
| Karkus Ted William | A | 3671318 | 600000 | 13 янв 2023 г. |
| Karkus Ted William | D | 1100000 | 600000 | 16 окт 2022 г. |
| Karkus Ted William | D | 3071318 | 317291 | 16 окт 2022 г. |
| Karkus Ted William | A | 3388609 | 600000 | 16 окт 2022 г. |
| Karkus Ted William | D | 1700000 | 600000 | 10 авг 2022 г. |
Новостная лента
ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?
Zacks Investment Research
03 мая 2023 г. в 05:20
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
7 Small-Cap Biotech Stocks with Massive Potential
InvestorPlace
27 апр 2023 г. в 18:36
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappointments or outright failures, these speculative enterprises are obviously less funded.
ProPhase Labs, Inc. (PRPH) Soars 7.5%: Is Further Upside Left in the Stock?
Zacks Investment Research
10 апр 2023 г. в 04:35
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ProPhase Labs: Lots Of Moving Pieces
Seeking Alpha
02 мар 2023 г. в 13:39
Medical diagnostic and testing concern ProPhase Labs, Inc. gets put in the spotlight today. ProPhase Labs, Inc. has seen huge revenue growth from Covid testing but is rapidly diversifying into other areas.
ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
GlobeNewsWire
30 ноя 2022 г. в 08:00
GARDEN CITY, NY, Nov. 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that it will be presenting at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022 at 2:30 pm EST. Ted Karkus, CEO, will be hosting the presentation.